Dr. Peadar O’Donohoe is Vice President, Clinical Development of Sudo Biosciences. Before joining Sudo, Peadar worked on clinical programs across multiple therapeutic areas, including neurology, sleep disorders, oncology, and hematology. His experience spans both early- and late-stage development and includes roles in Medical Affairs focused on advancing impactful clinical and scientific engagement. He has also been involved in the commercialization of medical devices.

Prior to industry, Peadar trained and practiced in anesthesiology and critical care, developing a foundation in broad hospital-based clinical practice and patient management, including central nervous system physiology.

Peadar received his medical degree (MBChB) from the University of Edinburgh and completed a Doctorate of Philosophy (DPhil) focused on cellular neurophysiology at the University of Oxford. He holds Specialist Registration with the UK General Medical Council in Pharmaceutical Medicine.